Summit Hotel Properties, Inc. (INN-PF)
| Previous Close | 20.68 |
| Open | 21.00 |
| Bid | 20.46 x 1100 |
| Ask | 20.75 x 800 |
| Day's Range | 20.16 - 21.00 |
| 52 Week Range | 20.16 - 27.02 |
| Volume | |
| Avg. Volume | 4,867 |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.21 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.11 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.47 (7.08%) |
| Ex-Dividend Date | Feb 11, 2022 |
| 1y Target Est | N/A |
- Newsfile
Innocan Pharma Obtains Receipt for Final Base Shelf Prospectus
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has filed and obtained a receipt for a final short form base shelf prospectus (the "Base Shelf Prospectus") with the securities regulatory authorities in each of the provinces and territories of Canada.The Base Shelf Prospectus allows Innocan to qualify the distribution of up to ...
- Newsfile
Innocan Pharma Announces the Successful Publication of a New Patent Application of Its New Sustained-Release (LPC) CBD Formulation
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that an International Patent Application ("PCT") titled "Protein-bound Cannabinoid Formulations and Uses Thereof" was recently published and received the publication number WO 2022/070191 (the "Patent Application"), claiming priority from a US provisional application filed in October 2020.The Patent Applicati
- Zacks
Summit Hotel Properties (INN) Q1 FFO and Revenues Top Estimates
Summit Hotel Properties (INN) delivered FFO and revenue surprises of 41.67% and 17.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
